PhD, University of Cape Town, 2008
MPH, Johns Hopkins Bloomberg School of Public Health, 1999
MD, University of Louvain Medical School, 1989
Jean Nachega, MD, PhD, MPH, FRCP, DTM&H, is a tenured Associate Professor of Epidemiology, Infectious Diseases and Microbiology at University of Pittsburgh, USA; Adjunct Associate Professor of Epidemiology and International Health at Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; and Professor Extraordinary and Director of the Centre for Infectious Diseases at Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa. He has >25 years’ experience of research, teaching, and professional activities have included planning, design, implementing, and monitoring clinical trials, cohort studies and programs to improve HIV treatment cascade outcomes in sub-Saharan Africa.
He conducted a seminal study that showed that the relationship between adherence to Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)-based HIV Therapy and virologic outcomes has linear dose-response pattern and is linked to various virologic outcomes. He was the first to quantify the savings in health care cost per month associated with excellent ART adherence, in a large South African HIV cohort. He has served as the Principal Investigator on several research and/or training grants, including some funded by US National Institutes of Health (NIH), US President Emergency Plan for AIDS Relief in Africa (PEPFAR), The European Developing Countries Clinical Trial Partnership (EDCTP), and The UK Wellcome Trust. He is Clinical Research Site (CRS) Lead Investigator for HIV studies in adults of the US NIH AIDS Clinical Trial Group (ACTG) Clinical Trial Unit (CTU) at Stellenbosch University. In addition, he is an ad hoc expert consultant for Bill and Melinda Gates Foundation; US Centers for Diseases Control & Preventions (CDC); and at World Health Organization (WHO), HIV Department, Geneva, within the HIV Treatment and Prevention Guidelines as well as HIV Drug Resistance Prevention Working Groups, as well as a member-elect of Academy of Sciences of South Africa (ASSAf) and African Academy of Sciences (AAS).
Honors and Awards
1) Member Elect, Delta Omega Public Health Honor Society , Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, May 2009; 2) John McGoldrick Senior Fellowship Award, Harvard School of Public Health, Boston, MA, USA, March 2009; 3) Member Elect, The Academy of Science of South Africa (ASSAF) 2008 and Fellow African Academy of Science (FAAS);4) Author (2nd) of a JAMA article nominated for the Lancet 2006 Article of the Year; 5) US National Institutes of Health/NIAID, Mentored-Patient Oriented Research Career Development Award (K23), March 2006; 6) Johns Hopkins Center for AIDS Research (CFAR) & National Institutes of Health (NIH), Pilot Grant Award, 2002; 7) Johns Hopkins University, School of Public Health Recognition Award, MPH Class of 1999; 8) Stelios M. Stelson Award, Johns Hopkins University, School of Public Health, MPH Class of 1999; 9) Dikembe Mutombo's African Education Award, Dikembe Mutombo Foundation, Atlanta, GA, 1998; 10) B.S. 1985, Magna Cum Laude & M.D. 1989, Cum Laude.